Q2: Members and prices up, costs better. Consumer resilience – recovery set to continue. '23 EPS up 8.8%, TP up to NOK 14 (13).

25 Aug 2023
Looking stronger

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Looking stronger
Sats ASA (SATS:STO), 0 | Satsuma Pharmaceuticals Inc (STSA:NYSE), 0 | SATS Ltd (S58:SES), 0 | SATS (SATS:SGX), 0 | SATS ASA (SATS:OSL), 0
- Published:
25 Aug 2023 -
Author:
ABGSC Services Research | Petter Nystrøm -
Pages:
14 -
Q2: Members and prices up, costs better. Consumer resilience – recovery set to continue. '23 EPS up 8.8%, TP up to NOK 14 (13).